A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer

Pancreatic cancer has one of the highest mortality rates among cancers, and a combination of nab-paclitaxel with gemcitabine remains the cornerstone of first-line therapy. However, major advances are required to achieve improvements in patient outcomes. For this reason, several research groups have...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapa-González, Christian, López, Karina, Lomelí, Kimberly Michelle, Roacho-Pérez, Jorge Alberto, Stevens, Jazmín Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953820/
https://www.ncbi.nlm.nih.gov/pubmed/35330078
http://dx.doi.org/10.3390/life12030327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953820/
https://www.ncbi.nlm.nih.gov/pubmed/35330078
http://dx.doi.org/10.3390/life12030327

Ejemplares similares